< Back to Glossary


Fenfluramine hydrochloride is an indirect 5-HT receptor agonist that was used as an anoretic i.e. an appetite reduction drug, sold under the brand name Pondimin.

It was removed from sale in 1997 because of significant safety fears that it contributed to the development of cardiac valvular disease.

Some people believe that it was a beneficial intervention for some of the problems faced by people with autism, although this was disputed by others.

Related Glossaries

Related Publications

There are 17 publications matching this term. Click Here to view the list (New Window).

About This Glossary

This glossary is designed to explain some of the jargon and gobbledygook used by some people when they talk about autism or research..

You may be able to find more information, including links to other parts of this website, by clicking on the title of an item.

If you can't find the word you are looking for, or you know of a word we should include, please email info@researchautism.net


The fact that an intervention is listed in this glossary does not necessarily mean that we agree with its use. Nor does it necessarily mean that there is any scientifically valid or reliable evidence behind it.